Journal
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 43, Issue 4, Pages 334-342Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejps.2011.05.011
Keywords
Neuroprotection; Retinal ganglion cells; Erythropoietin (EPO); Sustained-release
Categories
Funding
- Shanghai Rising-Star Program [10QH1400400, 2006QA14011]
- New Century training Program Foundation for Talent by the State Eduation Commission [NCET-05-0370]
- National Natural Science Foundation of China [NSFC81070764]
- Shanghai Science and Technology Commission [10JC1402302]
- National Basic Research Program of China [2007CB512204, 2007CB512205]
- Shanghai Committee of Science and Technology, China [1052nm03900]
- National Science Foundation of China Committee [30873180]
- National Grand New Drug Program [2009ZX09310-007, 2009ZX09301-007]
Ask authors/readers for more resources
This study explored a sustained neuroprotective erythropoietin (EPO) loaded composite microspheres system on injured retinal ganglion cells (RGC). The EPO was first loaded into dextran microparticles to keep its bioactivity using a novel aqueous-aqueous emulsion technique. The microspheres were finally formed by encapsulating the microparticles into Poly (DL-lactide-co-glycolide)/Poly (DL-lactide) (PLGA/PLA). A single dose of microspheres was intraperitoneally administrated on the optic nerve crush of rats and compared with multiple doses of EPO solution to investigate the long acting effect of microspheres on RGC. The results demonstrated that the release of microspheres could last for at least 60 days in an in vitro study. The animal experiments showed a similar neuroprotective effect between the single dose microspheres and the multiple doses of EPO solution. So we can draw a conclusion that the EPO-loaded PLGA/PLA microspheres were feasible for neurodegeneration diseases in the retina and central nervous system (CNS). (C) 2011 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available